These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibiotic prophylaxis for preventing burn wound infection. Barajas-Nava LA; López-Alcalde J; Roqué i Figuls M; Solà I; Bonfill Cosp X Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008738. PubMed ID: 23740764 [TBL] [Abstract][Full Text] [Related]
5. Topical therapy for control of bacteria in the burn wound. Moncrief JA World J Surg; 1978 Mar; 2(2):151-65. PubMed ID: 676330 [No Abstract] [Full Text] [Related]
6. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis. Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility testing of topical antimicrobial agents used in pediatric burn patients: comparison of two methods. Rodgers GL; Mortensen JE; Fisher MC; Long SS J Burn Care Rehabil; 1997; 18(5):406-10. PubMed ID: 9313120 [TBL] [Abstract][Full Text] [Related]
8. Prevention of bacterial growth and local infection in burn wounds. Linkner LM; Cloud DT; Trump DS; Dorman GW J Pediatr Surg; 1972; 7(3):310-4. PubMed ID: 4556791 [No Abstract] [Full Text] [Related]
9. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds. Boekema BK; Pool L; Ulrich MM Burns; 2013 Jun; 39(4):754-9. PubMed ID: 23036845 [TBL] [Abstract][Full Text] [Related]
10. Assessment of topical therapy of the burn wound with silver sulphadiazine after its use for 15 years in a burn unit. Koo DS; Zhen S; Zhen ZD; Shi XW; Xiang SJ Burns; 1989 Jun; 15(3):193-6. PubMed ID: 2757770 [TBL] [Abstract][Full Text] [Related]
11. Clinical comparison of maphenide and silver sulphadiazine. Pegg SP; Ramsay K; Meldrum L; Laundy M Scand J Plast Reconstr Surg; 1979; 13(1):95-101. PubMed ID: 451487 [TBL] [Abstract][Full Text] [Related]
12. The control of burn wound sepsis. MacMillan BG Intensive Care Med; 1981 Jan; 7(2):63-9. PubMed ID: 7204742 [TBL] [Abstract][Full Text] [Related]
13. Isolation care of infection-prone burn patients. Ransjö U Scand J Infect Dis Suppl; 1978; (11):1-46. PubMed ID: 97776 [TBL] [Abstract][Full Text] [Related]
14. [N1-metal sulfa drugs and zincpolyanemine and its derivatives in prevention of burn wound sepsis]. Ge SD Zhonghua Wai Ke Za Zhi; 1982 May; 20(5):264-6. PubMed ID: 7128331 [No Abstract] [Full Text] [Related]
15. [The treatment of burn wounds with silver sulfadiazine]. Vŭglenova E Khirurgiia (Sofiia); 1991; 44(3):53-7. PubMed ID: 1895712 [TBL] [Abstract][Full Text] [Related]
16. [Silver sulfadiazine (Flamazine). An antibacterial agent in the local prevention and therapy of burn wound infections]. Hoffmann S Ugeskr Laeger; 1984 Jul; 146(30):2250-2. PubMed ID: 6515819 [No Abstract] [Full Text] [Related]
17. Our experience with the use of cerium sulphadiazine in the treatment of extensive burns. Koller J; Orsag M Acta Chir Plast; 1998; 40(3):73-5. PubMed ID: 9782621 [TBL] [Abstract][Full Text] [Related]
18. Topical and systemic antimicrobial agents in burns. Ollstein RN; McDonald C Ann Plast Surg; 1980 Nov; 5(5):386-92. PubMed ID: 6779699 [TBL] [Abstract][Full Text] [Related]
19. Comparison of silver sulfadiazine 1% with chlorhexidine digluconate 0.2% to silver sulfadiazine 1% alone in the prophylactic topical antibacterial treatment of burns. Snelling CF; Inman RJ; Germann E; Boyle JC; Foley B; Kester DA; Fitzpatrick DJ; Warren RJ; Courtemanche AD J Burn Care Rehabil; 1991; 12(1):13-8. PubMed ID: 2022674 [TBL] [Abstract][Full Text] [Related]
20. Control of burn wound infection at the Royal Perth Hospital. Brooksbank M Aust N Z J Surg; 1979 Aug; 49(4):424-7. PubMed ID: 291404 [No Abstract] [Full Text] [Related] [Next] [New Search]